In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...